Bone Therapeutics Partners on Global ALLOB Rights

Bone Therapeutics and Link Health Pharma signed a non-binding term sheet for the global rights for ALLOB, Bone Therapeutics’ allogeneic bone cell therapy. The final agreement will be fully executed by the end of 2021.

This new partnership is separate and independent from the existing license agreement signed in October 2020 for the rights to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us